“…For example, changes in the regional levels of N -acetylaspartate/ N -acetyl-aspartyl-glutamate complex (tNAA), choline-phosphorylcholine-glycerophosphorylcholine complex (tCho), myo-inositol (mIns), gamma-aminobutyric acid (GABA), and glutamate-glutamine complex (Glx) which can be monitored in-vivo with proton-magnetic resonance spectroscopy ( 1 H-MRS), have been identified as potential biomarkers of disease progression in neurodegenerative disorders and dementia ( Ben Salem et al, 2008 , Ding et al, 2008 , Kantarci et al, 2007 ; Weerasekera et al, 2018; Zanigni et al, 2015 ). In healthy human volunteers, in-vivo quantification of brain neurometabolites with 1 H-MRS typically shows age-related declines in regional levels of multiple neurometabolites, including NAA, Glx, and GABA and increases in the levels of Cho and mIns ( Ding et al, 2016 , Gao et al, 2013 , Levin et al, 2019 , Porges et al, 2017 , Reyngoudt et al, 2012 , Vints et al, 2022 , Wijtenburg et al, 2013 , Zahr et al, 2013 ). For example, lower concentrations of NAA and Glx in sensorimotor cortex and lower Glx in the striatum were found to be strong predictors of performance declines on a variety of motor and cognitive tests performed by apparently healthy older adults ( Levin et al, 2019 , Weerasekera et al, 2020 , Zahr et al, 2008 , Zahr et al, 2013 ).…”